Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|August 10, 2010
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trialArno W R van Kuijk, Clarissa E Vergunst, Danielle M Gerlag, et al.
The Lancet. Rheumatology|January 26, 2024
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trialGeorg Schett, Chris Bainbridge, Mario Berkowitz, et al.
The Lancet. Rheumatology|January 27, 2024
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic studyMark C Genovese, Mario Berkowitz, Philip G Conaghan, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
Immunity|July 19, 2011
The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variantsKlaas P J M van Gisbergen, Paul L Klarenbeek, Natasja A M Kragten, et al.
Arthritis Research & Therapy|February 28, 2018
Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritisJanine S Hähnlein, Reza Nadafi, Tineke de Jong, et al.
Arthritis Research & Therapy|April 3, 2016
Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritisSamuel Garcia, Linda M Hartkamp, B Malvar-Fernandez, et al.
Arthritis and Rheumatism|August 20, 2010
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patientsRogier M Thurlings, Marie Boumans, Janneke Tekstra, et al.
The American Journal of Pathology|October 26, 2010
Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritisDaphne de Launay, Jeroen Vreijling, Linda M Hartkamp, et al.
Rheumatology (Oxford, England)|November 26, 2009
Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritisTineke Cantaert, Lisa G van Baarsen, Carla A Wijbrandts, et al.
Pageof 31